Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | Malaria Journal

Figure 4

From: Simulation of the cost-effectiveness of malaria vaccines

Figure 4

Effect of initial efficacy on cost-effectiveness of all vaccines delivered via EPI with 70-% mass vaccination by transmission setting*. Results obtained assuming a vaccine half-life of 10 years and homogeneity value of 10, and vaccine price of US$2. *data for EIR in some cases are not shown in the figure due to a scale problem.

Back to article page